A distance descriptor (6A) originally associated with nongenotoxic mouse carcinogens has been found to be present in some, but not all, estrogens and antiestrogens. It is hypothesized that this descriptor describes a ligand binding site on an estrogen receptor. Evidence is presented that those estrogens and antiestrogens not containing the 6A distance bind to a different receptor. It is conceivable that binding to the receptor that recognizes the 6A distance is associated with carcinogenicity.
metabolites, we were unable to identify either mutagenic or electrophilic metabolites that could be the basis of a 'genotoxic' mechanism of carcinogenicity (Cunningham and Rosenkranz, 1994) . In the course of these and related studies, we did, however, obtain evidence that the carcinogenicity of DES in mice was associated with a lipophilic 6A geometric distance descriptor (Cunningham and Rosenkranz, 1995) . Since this could reflect the presence of a ligand binding site, we further investigated the nature of the chemicals which contain this descriptor. The results of that study are reported herein.
Materials and methods

Expert system: CASE/MULT1CASE
For the present investigation, we used the MULTICASE (MC) program (Klopman, 1992; Klopman and Rosenkranz, 1994) . Basically, MC selects its own descriptors automatically from a learning set composed of active and inactive molecules. The descriptors are readily recognizable single, continuous structural fragments that are embedded in the complete molecule. The descriptors consist of either activating (biophore) or inactivating (biophobe) fragments. Each of these fragments is associated with a confidence level and a probability of activity which is derived from the distribution of these biophores and biophobes among active and inactive molecules.
Upon completion of these analyses, MC selects the most important of these fragments as a biophore, i.e. the functionality that is responsible for the experimentally observed activity of the molecules that contain it. MC then, using the molecules containing this biophore, will use them as a learning set to identify the chemical properties (i.e. structural fragments) or physical chemical properties (e.g. log P, water solubility, quantum mechanical parameters such as HOMO and LUMO, etc.) that modulate (either augment or decrease) the activity of the initially identified biophore. This will result in a QSAR equation for this subset of molecules. If the data set is congeneric, then the single biophore and associated modulators may explain the activity of the entire training set. This will usually not occur and there will be a residue of molecules not explained by the single biophore and related modulators. When this happens, the program will remove from consideration the molecules already explained by the previous biophore and will search for the next biophore and associated modulators. The process is continued until the activity of all of the molecules of the learning set has been explained.
The resulting list of biophores is then used to predict the activity of yet untested molecules. Thus, upon submission for evaluation, MC will determine if an unknown molecule contains a biophore. If it does not, the molecule will be predicted to be inactive unless it contains a group that chemically resembles one of the biophores, in which case it will be flagged. When the molecule contains a biophore, the presence of modulators for that biophore will be investigated. MC will then make qualitative as well as quantitative predictions of the activity of the unknown molecule.
Obviously, while biophores are the determining structures, the modulators may determine whether and to what extent the biological potential of the chemical is expressed.
Additionally, MC incorporates the following rules to identify two-dimensional distance descriptors based upon the presence of lipophilic centers. These two-dimensional distances are calculated from the molecular structure. Heteroatoms and lipophilic carbon atoms are designated as 'special' atoms. A carbon atom is designated as a lipophilic center if it is at least four bonds away from a heteroatom and is also the furthest carbon away from the heteroatom when its neighbors are considered. After all the 'special' atoms are identified, the distances between all possible pairs are calculated.
The distribution of these descriptors among active and inactive molecules is analyzed for statistical significance. If the atoms at both ends of the distance descriptor are all the same, including the number of attached hydrogeas, the biophore is designated an 'exact' descriptor. Various atom groupings are also investigated, i.e. hydrogen bond acceptors and donors as well as halogens. 
AnUestrogen
Additional hydroxylated putative metabolites of tamoxifen and toremifene also contain the 6A structural descriptor.
Expert system: META The expert system 'META', a computer based metabolism program, was used to investigate the metabolism of tamoxifen and tomerifene. The META program has recently been described in detail (Klopman et al., 1994; Talafous et al., 1994) . Briefly, META contains a knowledge set of 665 enzymecatalyzed and 286 spontaneous reactions which constitute most of the phase I and II metabolic pathways. When presented with the structure of a parent molecule, META indicates a series of possible metabolic pathways which include a graphical description of each possible metabolite(s) and intermediate metabolite(s) as well as the enzymes used to generate these.
Mouse carcinogenic potency database
The carcinogenic potency database was assembled by Gold et al. (1984 Gold et al. ( , 1986 Gold et al. ( , 1987 Gold et al. ( , 1990 Gold et al. ( , 1993 . A subset of mouse carcinogens (males and females) was derived from this compilation and subjected to MC analysis. In that database, chemicals reported as carcinogenic by the primary authors are accompanied by their TD50 values, i.e. the dose required for 50% of the animals to remain cancer-free (Gold et al., 1984; Peto et al., 1984) . These were transformed into gavage equivalents (Gold et al, 1984 (Gold et al, , 1986 Brown and Ashby 1990) . Additionally, the TDfo values (in mg/kg/day) were converted in mmolAg/day. Using equation (1) (see below), chemicals were assigned to activity groups. The database consists of 639 chemicals, 291 of which are carcinogens, 11 are marginal and 337 are non-carcinogens. Chemicals reported by the authors The molecules listed above were selected from among a group of 5400 molecules representative of the 'universe of chemicals' because they contain the 6A descriptor. In this analysis no consideration was given to the possible metabolism of these or the other molecules in the testing set. The 5400 chemicals tested represent a random selection of chemicals taken to reflect the 'universe of chemicals' (National Academy of Sciences, 1984) .
to be non-carcinogenic in mice were assigned 10 CASE units together with chemicals with a TD50 value in excess of 51 mmol/kg/day.
For the purpose of the SAR analysis, TD50 values (i.e. potencies) in mmol/ kg/day were transformed into CASE units using the following relationship: CASE activity = 14.1329 X (log IATO50) + 44.1329.
(1)
In order to accomodate the broad range of TO values present in the database, we chose to relate the TDjo values to CASE units in a logarithmic function. Thus, using equation 1, chemicals in the range of 10-19 CASE units are inactive or exhibit negligible activity. Chemicals with activities in the range of 20-29 CASE units are seen as marginally active and chemicals in the range of 30-99 CASE units are called carcinogenic.
It should be noted that since the database is for carcinogenicity in mice (males and females), the MULTICASE predictions do not specify the gender involved. Moreover, in the analyses no attempt was made to predict tissue-specificity.
Results and discussion
The 6A descriptor (see Figure 1) was originally identified as a biophore associated with carcinogenicity in mice (Cunningham and Rosenkranz, 1995) . That finding was based upon the Carcinogen Potency Database of Gold et al. (1984 Gold et al. ( , 1986 Gold et al. ( , 1987 Gold et al. ( , 1990 Gold et al. ( , 1993 . Among the chemicals in the database which contain this descriptor was estradiol and related chemicals (Figure 1) , thus suggesting that the 6A descriptor may be associated with estrogenicity. In order to determine whether this was the case, we tested a series of chemicals reported to be endowed with estrogenicity for the presence of the 6A descriptor. A number, but not all, of them displayed this property, suggesting that, indeed, this descriptor is related to estrogenicity. It should be noted that while the therapeutically useful anticancer agents tamoxifen and toremifene lack the 6A descriptor (Table I) , some of their metabolites contain it Indeed, among these are the metabolites which are believed to be responsible for the estrogenicity of tamoxifen (see Lerner and Jordan, 1990) . If it is assumed that the 6A descriptor identifies not only a biophore associated with murine carcinogenicity, but also an estrogen-receptor ligand, then the presence of this moiety in tamoxifen metabolites may explain the carcinogenicity as well as the estrogenicity of the parent molecule. Moreover, this suggests that the two phenomena may result from the same mechanism, i.e. binding to a specific site. If this is so, then it could be advantageous to design antiestrogens which lack the 6A descriptor and therefore bind to another receptor. In order to determine whether this is a viable alternative, we tested a number of estrogens and antiestrogens. It is of interest to note that some of these (e.g. ICI164, 384 and ICI182, 780) contain the 6A descriptor ( Figure  2 ) while others (e.g. LY 117018) do not (see Table I ). It has already been suggested that LY 117018 and tamoxifen (Black and Goode, 1981; Scholl et al., 1983) and LY 117018 and ICI 164,384/ICI 182,780 (Coradini et al., 1994) have different bases for their antiestrogenicity. The present findings together with the previously reported dichotomy of the action of antiestrogens, suggests that the latter may act by different mechanisms. Our findings further suggest the possibility that the 6A distance descriptor identifies a ligand binding site on one of the estrogen receptors. If, indeed, the 6A biophore is associated with rodent carcinogenicity, then perhaps targeting the estrogen receptor which does not recognize this moiety may be a promising endeavor for the development of therapeutically useful antiestrogens.
As mentioned earlier, the 6A biophore was first identified using a rodent carcinogenicity database which is not congeneric with respect to chemical species. Accordingly, the modulators identified as associated with this biophore may not provide a complete understanding of the factors affecting activity.
In order to further explore the nature of the 6A biophore, the database was supplemented with a series of diverse molecules containing these descriptors (n = 31) as well as with congeners lacking it (n = 9). Upon analysis of this 'synthetic' learning set with MULTICASE, the 6A biophore was once again identified (P < 0.01). However, the nature of the modulators associated with this biophore permitted a further delineation of their nature. Thus, all of the modulators are within the 6A domain and describe moieties that either enhance or decrease the projected activity (see Figure 3) . Moreover, the physical chemical modulator affecting this biophore is the log P (octanol: water partition coefficient) which further substantiates that the 6A biophore encompasses a lipophilic center. Thus, the modulators are consistent with the possibility that the 6A biophore describes a ligand which is recognized by a specific receptor.
Finally, in order to gain an understanding of the possible distribution of the 6A biophore among molecules, we determined its presence among molecules (n = 5400) representing the 'universe of chemicals'. Some of the chemicals containing this moiety are listed in Table II and it is of interest that it is present in a wide selection of agents, some of which are in widespread use (e.g. BHT), others which are used in cancer chemotherapy (e.g. NSC377163) and still others which are used in traditional medicine (e.g. hemigossypol). Some of these might be endowed with estrogenicity. It is of further interest that some hydroxylated metabolites of polycyclic aromatic hydrocarbons (e.g. 11-hydroxypyrene, 5-hydroxydibenz(a,h)anthracene, 3-hydroxy-7,12-dimethylbenz[a]anthracene) contain the 6A biophore (Table II) . The estrogenicity of polycyclic aromatic hydrocarbons is a recognized phenomenon (Davis et al., 1993; Safe, 1995) .
The current findings suggest a number of additional studies that should lead to a further refinement of the biophore as well as a better understanding of its relevance to the induction of cancer and estrogenicity. Moreover, the recognition of at least two classes of estrogens differing in a geometric descriptor may enable us to identify the nature of the ligand which binds to the other estrogen receptors.
The present report documents the existence of a structural descriptor which appears to be related to non-genotoxic carcinogens. Moreover, the new biophore implies a mechanism of action as well. This indicates the feasibility of applying SAR approaches to non-genotoxic carcinogens.
